Currency Exchange Hits Roche's Q1 MDx, Applied Science Revenues

The firm's molecular diagnostics sales were down in Swiss francs, but up in local currency. Its applied science sales fell on a tougher comp with Q1 of 2010.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories